Compare $AIM vs $APRE | Chartloom

Compare

$AIM vs $APRE

AIM ImmunoTech Inc · Aprea Therapeutics Inc

AIM

AIM ImmunoTech Inc

APRE

Aprea Therapeutics Inc

Compare $AIM vs $APRE

Comparing AIM ImmunoTech Inc and Aprea Therapeutics Inc

AIMAIM ImmunoTech Inc

APREAprea Therapeutics Inc

AIMAIM ImmunoTech Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-21.5%

YTD performance

-84.4%

52W performance

-92.8%

FCF yield

-292.9%

APREAprea Therapeutics Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-99.4%

YTD performance

-29.1%

52W performance

-57.8%

FCF yield

-162.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AIM

APRE

Detailed metrics comparison

AIM

AIM ImmunoTech Inc

APRE

Aprea Therapeutics Inc

Market Cap

AIM$5M

APRE$7M

Enterprise Value

AIM$-1M

APRE$-34M

Price

AIM$0.18

APRE$0.60

P/E Ratio

AIMN/A

APREN/A

P/S Ratio

AIM52.52x

APRE1,438.94x

EV/Sales

AIM-13.57x

APRE-6,490.56x

EV/EBITDA

AIM0.00x

APRE0.00x

P/B Ratio

AIM0.91x

APRE0.22x

P/FCF Ratio

AIMN/A

APREN/A

EV/FCF

AIM0.09x

APRE2.77x

PEG Ratio

AIMN/A

APREN/A

Forward P/E (NTM)

AIMN/A

APREN/A

Forward P/S (NTM)

AIMN/A

APREN/A

Revenue (TTM)

AIM$95K

APRE$5K

Revenue Growth (YoY)

AIM-21.5%

APRE-99.4%

Forward Rev Growth

AIM-32.4%

APRE445.8%

Gross Margin (TTM)

AIM-23.2%

APRE0.0%

Operating Margin (TTM)

AIM0.0%

APRE0.0%

EBITDA Margin (TTM)

AIM-10985.3%

APRE-253869.2%

Net Margin (TTM)

AIM-15021.1%

APRE-236676.9%

FCF Margin (TTM)

AIM-15385.3%

APRE-234296.2%

Net Income (TTM)

AIM$-14M

APRE$-12M

FCF (TTM)

AIM$-15M

APRE$-12M

EPS (TTM)

AIM-$0.83

APRE-$0.23

ROE (TTM)

AIM-13803.0%

APRE-4630.0%

ROA (TTM)

AIM-17514.0%

APRE-4097.0%

ROIC (TTM)

AIM-7694.0%

APRE-4630.0%

Cash

AIM$10M

APRE$41M

Debt

AIM$4M

APRE$0

Net Cash/Debt

AIM$6M

APRE$41M

Current Ratio (TTM)

AIM2.11x

APRE13.55x

Quick Ratio (TTM)

AIM2.01x

APRE13.33x

Debt/Equity (TTM)

AIM0.47x

APRE0.00x

Debt/Assets (TTM)

AIM0.0%

APRE0.0%

Interest Coverage (TTM)

AIMN/A

APREN/A

Net Debt/EBITDA (TTM)

AIM0.00x

APRE0.00x

Beta

AIM1.35

APRE-1.23

52W Performance

AIM-92.8%

APRE-57.8%

YTD Performance

AIM-84.4%

APRE-29.1%

% from 52W High

AIM-93.6%

APRE-64.2%

% from 52W Low

AIM8.4%

APRE10.3%

Asset Turnover (TTM)

AIM0.01x

APRE0.02x

FCF Yield (TTM)

AIM-292.9%

APRE-162.8%

Earnings Yield (TTM)

AIM-286.0%

APRE-164.5%

Dividend Yield (TTM)

AIMN/A

APREN/A

Rule of 40

AIM-15,406.8

APRE-234,395.5

EV/GP/RG

AIMN/A

APREN/A

Ticker research

View AIM research View APRE research

Metric	AIM AIM ImmunoTech Inc	APRE Aprea Therapeutics Inc
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-1M	$-34M
Price	$0.18	$0.60
P/E Ratio	N/A	N/A
P/S Ratio	52.52x	1,438.94x
EV/Sales	-13.57x	-6,490.56x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.91x	0.22x
P/FCF Ratio	N/A	N/A
EV/FCF	0.09x	2.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$95K	$5K
Revenue Growth (YoY)	-21.5%	-99.4%
Forward Rev Growth	-32.4%	445.8%
Profitability
Gross Margin (TTM)	-23.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10985.3%	-253869.2%
Net Margin (TTM)	-15021.1%	-236676.9%
FCF Margin (TTM)	-15385.3%	-234296.2%
Net Income (TTM)	$-14M	$-12M
FCF (TTM)	$-15M	$-12M
EPS (TTM)	-$0.83	-$0.23
ROE (TTM)	-13803.0%	-4630.0%
ROA (TTM)	-17514.0%	-4097.0%
ROIC (TTM)	-7694.0%	-4630.0%
Financial Health
Cash	$10M	$41M
Debt	$4M	$0
Net Cash/Debt	$6M	$41M
Current Ratio (TTM)	2.11x	13.55x
Quick Ratio (TTM)	2.01x	13.33x
Debt/Equity (TTM)	0.47x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.35	-1.23
52W Performance	-92.8%	-57.8%
YTD Performance	-84.4%	-29.1%
% from 52W High	-93.6%	-64.2%
% from 52W Low	8.4%	10.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.02x
FCF Yield (TTM)	-292.9%	-162.8%
Earnings Yield (TTM)	-286.0%	-164.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-15,406.8	-234,395.5
EV/GP/RG	N/A	N/A
Ticker research	View AIM research	View APRE research

Valuation

P/S Ratio

AIM

52.52x

APRE

1,438.94x

EV/FCF

AIM

0.09x

APRE

2.77x

Growth & revenue

Revenue Growth TTM

AIM

-21.5%

APRE

-99.4%

Forward Revenue Growth

APRE

445.8%

AIM

-32.4%

Profitability & performance

Gross Margin

APRE

0.0%

AIM

-23.2%

ROE

APRE

-4630.0%

AIM

-13803.0%

FCF Yield %

APRE

-162.8%

AIM

-292.9%

52-Week Performance

APRE

-57.8%

AIM

-92.8%

Detailed metrics comparison

AIM

AIM ImmunoTech Inc

APRE

Aprea Therapeutics Inc

Market Cap

AIM$5M

APRE$7M

Enterprise Value

AIM$-1M

APRE$-34M

Price

AIM$0.18

APRE$0.60

P/E Ratio

AIMN/A

APREN/A

P/S Ratio

AIM52.52x

APRE1,438.94x

EV/Sales

AIM-13.57x

APRE-6,490.56x

EV/EBITDA

AIM0.00x

APRE0.00x

P/B Ratio

AIM0.91x

APRE0.22x

P/FCF Ratio

AIMN/A

APREN/A

EV/FCF

AIM0.09x

APRE2.77x

PEG Ratio

AIMN/A

APREN/A

Forward P/E (NTM)

AIMN/A

APREN/A

Forward P/S (NTM)

AIMN/A

APREN/A

Revenue (TTM)

AIM$95K

APRE$5K

Revenue Growth (YoY)

AIM-21.5%

APRE-99.4%

Forward Rev Growth

AIM-32.4%

APRE445.8%

Gross Margin (TTM)

AIM-23.2%

APRE0.0%

Operating Margin (TTM)

AIM0.0%

APRE0.0%

EBITDA Margin (TTM)

AIM-10985.3%

APRE-253869.2%

Net Margin (TTM)

AIM-15021.1%

APRE-236676.9%

FCF Margin (TTM)

AIM-15385.3%

APRE-234296.2%

Net Income (TTM)

AIM$-14M

APRE$-12M

FCF (TTM)

AIM$-15M

APRE$-12M

EPS (TTM)

AIM-$0.83

APRE-$0.23

ROE (TTM)

AIM-13803.0%

APRE-4630.0%

ROA (TTM)

AIM-17514.0%

APRE-4097.0%

ROIC (TTM)

AIM-7694.0%

APRE-4630.0%

Cash

AIM$10M

APRE$41M

Debt

AIM$4M

APRE$0

Net Cash/Debt

AIM$6M

APRE$41M

Current Ratio (TTM)

AIM2.11x

APRE13.55x

Quick Ratio (TTM)

AIM2.01x

APRE13.33x

Debt/Equity (TTM)

AIM0.47x

APRE0.00x

Debt/Assets (TTM)

AIM0.0%

APRE0.0%

Interest Coverage (TTM)

AIMN/A

APREN/A

Net Debt/EBITDA (TTM)

AIM0.00x

APRE0.00x

Beta

AIM1.35

APRE-1.23

52W Performance

AIM-92.8%

APRE-57.8%

YTD Performance

AIM-84.4%

APRE-29.1%

% from 52W High

AIM-93.6%

APRE-64.2%

% from 52W Low

AIM8.4%

APRE10.3%

Asset Turnover (TTM)

AIM0.01x

APRE0.02x

FCF Yield (TTM)

AIM-292.9%

APRE-162.8%

Earnings Yield (TTM)

AIM-286.0%

APRE-164.5%

Dividend Yield (TTM)

AIMN/A

APREN/A

Rule of 40

AIM-15,406.8

APRE-234,395.5

EV/GP/RG

AIMN/A

APREN/A

Ticker research

View AIM research View APRE research

Metric	AIM AIM ImmunoTech Inc	APRE Aprea Therapeutics Inc
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-1M	$-34M
Price	$0.18	$0.60
P/E Ratio	N/A	N/A
P/S Ratio	52.52x	1,438.94x
EV/Sales	-13.57x	-6,490.56x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.91x	0.22x
P/FCF Ratio	N/A	N/A
EV/FCF	0.09x	2.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$95K	$5K
Revenue Growth (YoY)	-21.5%	-99.4%
Forward Rev Growth	-32.4%	445.8%
Profitability
Gross Margin (TTM)	-23.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10985.3%	-253869.2%
Net Margin (TTM)	-15021.1%	-236676.9%
FCF Margin (TTM)	-15385.3%	-234296.2%
Net Income (TTM)	$-14M	$-12M
FCF (TTM)	$-15M	$-12M
EPS (TTM)	-$0.83	-$0.23
ROE (TTM)	-13803.0%	-4630.0%
ROA (TTM)	-17514.0%	-4097.0%
ROIC (TTM)	-7694.0%	-4630.0%
Financial Health
Cash	$10M	$41M
Debt	$4M	$0
Net Cash/Debt	$6M	$41M
Current Ratio (TTM)	2.11x	13.55x
Quick Ratio (TTM)	2.01x	13.33x
Debt/Equity (TTM)	0.47x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.35	-1.23
52W Performance	-92.8%	-57.8%
YTD Performance	-84.4%	-29.1%
% from 52W High	-93.6%	-64.2%
% from 52W Low	8.4%	10.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.02x
FCF Yield (TTM)	-292.9%	-162.8%
Earnings Yield (TTM)	-286.0%	-164.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-15,406.8	-234,395.5
EV/GP/RG	N/A	N/A
Ticker research	View AIM research	View APRE research